Athira Pharma
ATHA
ATHA
98 hedge funds and large institutions have $71.9M invested in Athira Pharma in 2022 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 98 → 98 (0)
0% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 20
Holders
98
Holding in Top 10
–
Calls
$2.5M
Puts
$254K
Top Buyers
| 1 | +$5.77M | |
| 2 | +$748K | |
| 3 | +$718K | |
| 4 |
Renaissance Technologies
New York
|
+$698K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$658K |
Top Sellers
| 1 | -$1.25M | |
| 2 | -$1.21M | |
| 3 | -$671K | |
| 4 |
JG
Jefferies Group
New York
|
-$614K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$522K |